[Placebo-controlled study of the effects of a standardized MORA bioresonance therapy on functional gastrointestinal complaints].
OBJECTIVE
Many practitioners of natural medicine as well as a non-controlled study have reported about positive effects of MORA bioresonance therapy on psychosomatic diseases. The present placebo controlled study aimed to test the effects of MORA bioresonance therapy on non-organic gastro-intestinal complaints.


METHODS
A randomized, placebo controlled study was carried out on 20 participants (10 in the placebo group, 10 in the verum group). The main outcome parameters were the patients' and the physician's estimation of the intensity and frequency of gastro-intestinal complaints as well as the examination results recorded by the physician: stomach pain by palpation, meteorism by percussion and intestinal noise by auscultation, assessed pre and post treatment. Secondary outcome parameters were the electric resistance between hands and feet, data from feces, urine and blood, and the subjective general condition of body, mind and soul.


RESULTS
According to the participants' and the physician's estimation the intensity and frequency of the gastro-intestinalcomplaints were markedly and significantly reduced in theverum group (p < 0.01). This was also true for stomach pain(p < 0.01) and meteorism (p < 0.05), but not for intestinal noise (p > 0.05). The main outcome parameters in the placebo group changed only slightly (p > 0.05).


CONCLUSIONS
TheMORA bioresonance therapy can markedly improve non-organic gastro-intestinal complaints.
Nienhaus
Jürgen
J
Internistisch-naturheilkundliche Praxis, Mülheim, Deutschland.
Galle
Michael
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004599:Electric Stimulation Therapy / Q000379:methods*; D004574:Electromagnetic Fields; D005260:Female; D005767:Gastrointestinal Diseases / Q000628:therapy*; D006801:Humans; D008280:Magnetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011602:Psychophysiologic Disorders / Q000628:therapy*; D016896:Treatment Outcome
D010919:Placebos